Castle Biosciences Inc (CSTL) — 10-Q Filings

10-Q Filings (6)

• Castle Biosciences Swings to Loss Amid Soaring Amortization Costs — Nov 3, 2025 Risk: high
  CASTLE BIOSCIENCES INC reported a net loss of $501 thousand for the three months ended September 30, 2025, a significant decline from a net income of $2.269 mil
• Castle Biosciences' Q2 Loss Widens to $28.1M Amid R&D Push — Aug 4, 2025 Risk: high
  CASTLE BIOSCIENCES INC reported a net loss of $28.1 million for the three months ended June 30, 2025, a significant increase from the $20.5 million net loss in
• Castle Biosciences Q1 2025 10-Q Filed — May 5, 2025 Risk: medium
  Castle Biosciences Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quar
• Castle Biosciences Files Q3 2024 10-Q — Nov 4, 2024 Risk: medium
  Castle Biosciences Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third
• Castle Biosciences Files Q2 2024 10-Q — Aug 5, 2024 Risk: medium
  Castle Biosciences Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quar
• Castle Biosciences Inc. Files 10-Q for Period Ending March 31, 2024 — May 2, 2024 Risk: medium
  CASTLE BIOSCIENCES INC (CSTL) filed a Quarterly Report (10-Q) with the SEC on May 2, 2024. Castle Biosciences Inc. filed a 10-Q report for the period ending Mar

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX